tradingkey.logo

electroCore, Inc.

ECOR
5.450USD
+0.380+7.50%
Close 02/06, 16:00ETQuotes delayed by 15 min
41.61MMarket Cap
LossP/E TTM

electroCore, Inc.

5.450
+0.380+7.50%

More Details of electroCore, Inc. Company

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.

electroCore, Inc. Info

Ticker SymbolECOR
Company nameelectroCore, Inc.
IPO dateJun 22, 2018
CEOGoldberger (Daniel S)
Number of employees73
Security typeOrdinary Share
Fiscal year-endJun 22
Address200 Forge Way
CityROCKAWAY
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07866
Phone19732900097
Websitehttps://www.electrocore.com/
Ticker SymbolECOR
IPO dateJun 22, 2018
CEOGoldberger (Daniel S)

Company Executives of electroCore, Inc.

Name
Name/Position
Position
Shareholding
Change
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
232.27K
+46375.00%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+19011.00%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+19011.00%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+19011.00%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
+30549.00%
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Julie A. Goldstein
Ms. Julie A. Goldstein
Independent Director
Independent Director
--
--
Mr. Joshua S. Lev
Mr. Joshua S. Lev
Chief Financial Officer
Chief Financial Officer
--
--
Mr. James C. Theofilos
Mr. James C. Theofilos
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
232.27K
+46375.00%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+19011.00%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+19011.00%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+19011.00%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
+30549.00%
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Health and Wellness Products
6.81M
78.37%
Prescription Devices
1.88M
21.63%
By RegionUSD
Name
Revenue
Proportion
United States
8.22M
94.63%
United Kingdom
402.00K
4.63%
Other
48.00K
0.55%
Japan
17.00K
0.20%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Health and Wellness Products
6.81M
78.37%
Prescription Devices
1.88M
21.63%

Shareholding Stats

Updated: Fri, Feb 6
Updated: Fri, Feb 6
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
The Vanguard Group, Inc.
3.04%
Other
72.98%
Shareholders
Shareholders
Proportion
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
The Vanguard Group, Inc.
3.04%
Other
72.98%
Shareholder Types
Shareholders
Proportion
Individual Investor
27.86%
Corporation
8.76%
Investment Advisor
7.46%
Investment Advisor/Hedge Fund
1.59%
Hedge Fund
1.57%
Research Firm
0.02%
Other
52.74%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
75
727.72K
16.70%
--
2025Q3
75
727.72K
17.61%
-444.98K
2025Q2
70
1.17M
19.50%
-199.13K
2025Q1
65
1.37M
13.77%
+380.78K
2024Q4
69
936.59K
18.00%
-138.83K
2024Q3
59
1.06M
17.69%
+20.62K
2024Q2
62
1.04M
19.14%
+51.56K
2024Q1
68
992.08K
19.07%
-152.78K
2023Q4
66
961.96K
18.72%
+22.04K
2023Q3
73
937.71K
13.66%
+316.94K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Zhang (Tianyi)
734.64K
9.19%
+734.64K
--
May 15, 2025
Theofilos (Charles Steve)
444.53K
5.56%
--
--
Jul 04, 2025
Hilve Holdings Ltd
432.00K
5.4%
+432.00K
--
Aug 15, 2025
Errico (Thomas J.)
306.38K
3.83%
+26.61K
+9.51%
Sep 02, 2025
The Vanguard Group, Inc.
233.47K
2.92%
+1.14K
+0.49%
Sep 30, 2025
Goldberger (Daniel S)
185.90K
2.32%
+1.00K
+0.54%
Dec 02, 2025
Happy Holstein Management, LLC
153.17K
1.92%
--
--
Jul 04, 2025
MAZ Partners, L.P.
115.52K
1.44%
-156.44K
-57.52%
May 13, 2025
Patton (Thomas M)
102.78K
1.29%
+19.01K
+22.69%
Sep 02, 2025
Goldstein (Julie Ann)
101.39K
1.27%
+19.01K
+23.08%
Sep 02, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Date
Ex-dividend Date
Type
Ratio
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
KeyAI